C07K 16/1143
Gag-pol proteins
Official title: {Gag-pol proteins, e.g. p17or p24}
C07K16/1143 (Gag-pol proteins) appears on 94 US grants and 66 published applications in this corpus.
Search patents in C07K- Granted patents
- 94
- Published applications
- 66
- Assignees
- 71
- Inventors
- 198
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 6 | 0 |
| 1998 | 6 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 1 |
| 2002 | 5 | 4 |
| 2003 | 3 | 3 |
| 2004 | 2 | 5 |
| 2005 | 2 | 9 |
| 2006 | 1 | 1 |
| 2007 | 0 | 3 |
| 2008 | 0 | 1 |
| 2009 | 7 | 3 |
| 2010 | 3 | 6 |
| 2011 | 2 | 2 |
| 2012 | 1 | 5 |
| 2013 | 2 | 6 |
| 2014 | 6 | 3 |
| 2015 | 2 | 2 |
| 2016 | 4 | 0 |
| 2017 | 3 | 1 |
| 2018 | 1 | 2 |
| 2019 | 2 | 1 |
| 2020 | 1 | 1 |
| 2021 | 3 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 1 | 3 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-human immunodeficiency virus-1 antibodies and methods for uses thereof29 Sep 2026US 12,747,285 B2Grifols Diagnostic Solutions Inc.
- HIV specific binding molecules1 Oct 2024US 12,103,971 B2Immunocore Limited
- Methods of making active antibodies from biological fluids20 Jul 2021US 11,067,583 B2The United States Government as represented by the Department of Veterans Affairs
- Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats2 Feb 2021US 10,905,757 B2University of Florida Research Foundation, Inc.
- Methods of making heavy chain only antibodies using transgenic animals2 Feb 2021US 10,906,970 B2Erasmus University Medical Centre
- Antibody against human immunodeficiency virus type 1 p24 and type 2 p26 and uses thereof30 Apr 2026US 2026/0118359 A1Hytest Ltd.
- Binder molecules with high affinity and/ or specificity and methods of making and use thereof19 Jun 2025US 2025/0199010 A1Alamar Biosciences, Inc.
- Luminescent based antigen assay31 Oct 2024US 2024/0361321 A1
- Anti-human immunodeficiency virus-1 antibodies and methods for uses thereof18 Jul 2024US 2024/0239876 A1Grifols Diagnostic Solutions Inc.
- Methods for characterizing lentiviruses27 Jun 2024US 2024/0210385 A1Lonza Houston, Inc.
Most cited
By later US patents
- Enzyme immunoassay for detecting HIV antigens in human sera43US 4,886,742 ACoulter Corporation · 1989
- Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their CNS carrier and uses thereof40US 5,556,757 AInsight Biotek, Inc. · 1996
- Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody36US 6,146,627 ASidney Kimmel Cancer Center · 2000
- Cloning and expression of HTLV-III DNA35US 6,001,977 AThe United States of America as represented by the Department of Health and Human Services · 1999
- HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus31US 4,983,387 AViral Technologies, Inc. · 1991